Work

Phase 1 dose escalation study of copanlisib (BAY 80-6946) in combination with gemcitabine or gemcitabine-cisplatin in advanced cancer patients.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.15_suppl.2610

Authors: Richard D. Kim, Steven R. Alberts, Frank Gary Renshaw, Isabelle Genvresse, Stefanie Reif, Jennifer Kaplan, Juneko E. Grilley-Olson

Institutions: Moffitt Cancer Center, Mayo Clinic, Bayer (United States), University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2907177444

Cites:

Cited by: 6

Related to: 10